Randomized controlled trial of a positive affect intervention for methamphetamine users

Amphetamine-type stimulants such as methamphetamine are the second most commonly used illicit substances with an estimated 19.3 – 54.8 million users worldwide (United Nations Office on Drugs and Crime, 2017). Agonist therapies and mirtazapine have shown some promise (Coffin et al., 2013; Coffin et al., 2018; Colfax et al., 2011; Karila et al., 2010), but there is currently no widely approved pharmacotherapy for the treatme nt of stimulant use disorders. Although behavioral interventions have demonstrated modest effectiveness (Carrico et al., 2016b; Colfax et al., 2010), novel approaches are needed to achieve greater reductions in stimulant use.

Source: Drug and Alcohol Dependence - September 4, 2018 Category: Addiction Authors: Adam W. Carrico, Walter G όmez, Jennifer Jain, Steven Shoptaw, Michael V. Discepola, David Olem, Justin Lagana-Jackson, Rick Andrews, Torsten B. Neilands, Samantha E. Dilworth, Jennifer L. Evans, William J. Woods, Judith T. Moskowitz Tags: Full length article Source Type: research